Discovery Indigenous Researchers Development - Grant ID: DI0989521
Funder
Australian Research Council
Funding Amount
$150,000.00
Summary
A Qualitative Study of Barriers to Effective Infectious and Parasitic Disease Interventions in Aboriginal Communities. This project is significant and innovative as it will enhance current understandings of the experience Indigenous communities have with infectious diseases. To date there have been no significant qualitative studies that examine the perceptions Indigenous communities have about infectious disease treatment interventions that draw on their current knowledge, experiences and on he ....A Qualitative Study of Barriers to Effective Infectious and Parasitic Disease Interventions in Aboriginal Communities. This project is significant and innovative as it will enhance current understandings of the experience Indigenous communities have with infectious diseases. To date there have been no significant qualitative studies that examine the perceptions Indigenous communities have about infectious disease treatment interventions that draw on their current knowledge, experiences and on health, functionality and well-being. This study will develop a model that Indigenous communities, clinicians, policy makers and researchers can use to guide the implementation of sustainable infectious disease interventions. The outcomes of this project will help guide, inform and improve future infectious disease intervention strategies and programs.Read moreRead less
Production and application of novel diagnostic and therapeutic reagents using transgenic mice. The project will be a collaboration between the University of Queensland and PanBio Ltd. We intend to use humanized transgenic mice to produce fully human monoclonal antibodies. Fully human antibodies have great advantages over murine antibodies as diagnostics and therapeutics. These reagents will be used to 1)replace human sera , 2)replace antigens from infectious organisms in a range of diagnostic ....Production and application of novel diagnostic and therapeutic reagents using transgenic mice. The project will be a collaboration between the University of Queensland and PanBio Ltd. We intend to use humanized transgenic mice to produce fully human monoclonal antibodies. Fully human antibodies have great advantages over murine antibodies as diagnostics and therapeutics. These reagents will be used to 1)replace human sera , 2)replace antigens from infectious organisms in a range of diagnostic kits for animal and human infectious disease and 3) as therapeutic leads and 4)to discover vaccine leads. The project will allow production of diagnostic kits where this was previously not feasible or not economically viable (eg. uncommon and/or dangerous animal or human diseases) and will lead to development of novel infectious disease diagnostics and therapeutics.Read moreRead less
Special Research Initiatives - Grant ID: SR0567493
Funder
Australian Research Council
Funding Amount
$99,146.00
Summary
E-Services for Comparative Studies in Molecular Biology. The central challenge of post-genomic biology is to exploit the range of sequence and microarray data to yield greater understanding of biological processes. Large comparative studies are hamstrung by the inaccessibility of specialist comparative tools and the problem of managing large-scale disparate data. This project will provide portal and web services facilities to remove these obstacles, relying on robust and scalable business techno ....E-Services for Comparative Studies in Molecular Biology. The central challenge of post-genomic biology is to exploit the range of sequence and microarray data to yield greater understanding of biological processes. Large comparative studies are hamstrung by the inaccessibility of specialist comparative tools and the problem of managing large-scale disparate data. This project will provide portal and web services facilities to remove these obstacles, relying on robust and scalable business technologies to be made freely available. Our work will be driven by specific applications in bacterial genomics and cancer research, and will support research into prostate cancer and the pathogens Chlamydia and Bacillus anthracis.Read moreRead less
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE0561013
Funder
Australian Research Council
Funding Amount
$220,000.00
Summary
X-ray diffraction System for Protein Crystallography and Structural Biology. Knowledge of protein structures enables researchers to explain cellular function at a molecular level. In particular, it provides essential information to understand the mechanism of diseases, such as cancer or AIDS, and it ultimately leads to the design of better drugs.
An in-house X-ray protein crystallography facility will allow us to determine the structures of key proteins effectively and competitively, opening up ....X-ray diffraction System for Protein Crystallography and Structural Biology. Knowledge of protein structures enables researchers to explain cellular function at a molecular level. In particular, it provides essential information to understand the mechanism of diseases, such as cancer or AIDS, and it ultimately leads to the design of better drugs.
An in-house X-ray protein crystallography facility will allow us to determine the structures of key proteins effectively and competitively, opening up extensive possibilities for multi-disciplinary ground-breaking research.
The University research portfolio has evolved to embrace the revolution in structural biology with numerous projects and collaborations focusing on proteins involved in bacterial infections, degenerative disorders and biotechnological applications.Read moreRead less
Development of an effective vaccine for chlamydial infection: optimisation of a non-toxic cholera toxin-based adjuvant to generate a protective mucosal response. Chlamydial genital infections are the most common sexually transmitted infection in Australia and the world and impose a major health burden on the community. Chlamydial infections are also associated with cardiovascular disease, Australia's biggest killer and asthma, another condition that has increased significantly in prevalence in t ....Development of an effective vaccine for chlamydial infection: optimisation of a non-toxic cholera toxin-based adjuvant to generate a protective mucosal response. Chlamydial genital infections are the most common sexually transmitted infection in Australia and the world and impose a major health burden on the community. Chlamydial infections are also associated with cardiovascular disease, Australia's biggest killer and asthma, another condition that has increased significantly in prevalence in the past 10 years. This project will evaluate the effectiveness of a new adjuvant as a first step towards the development of a vaccine to target these important infections.Read moreRead less
Ross River virus - identification of virulence determinants in clinical isolates from across Australia. In Australia, Ross River virus (RRV) is the most common insect borne virus that affects human health. There were more than 60,000 confirmed cases of RRV between 1993 and 2008. While not fatal, the disease is responsible for significant morbidity that has both social and economic costs for the individual, their family and the community. The project has several national benefits. It will elucida ....Ross River virus - identification of virulence determinants in clinical isolates from across Australia. In Australia, Ross River virus (RRV) is the most common insect borne virus that affects human health. There were more than 60,000 confirmed cases of RRV between 1993 and 2008. While not fatal, the disease is responsible for significant morbidity that has both social and economic costs for the individual, their family and the community. The project has several national benefits. It will elucidate whether there is any association between RRV strain and the severity of human disease. It will also identify viral markers that could assist public health officials in determining likely disease outcomes of outbreaks and could provide new avenues for the design of antiviral strategies.Read moreRead less
An Investigation of Novel Sialylmimetics as Inhibitors of Rotavirus. Rotavirus causes severe gastroenteritis in infants worldwide. Over 125 million cases of diarrhoea and 800,000 deaths annually are attributed to rotavirus. The process that enables this debilitating and sometimes fatal disease to infect cells is poorly understood. This project aims to produce a range of unique chemical entities that will provide information about the way rotavirus infects cells. The chemical compounds produc ....An Investigation of Novel Sialylmimetics as Inhibitors of Rotavirus. Rotavirus causes severe gastroenteritis in infants worldwide. Over 125 million cases of diarrhoea and 800,000 deaths annually are attributed to rotavirus. The process that enables this debilitating and sometimes fatal disease to infect cells is poorly understood. This project aims to produce a range of unique chemical entities that will provide information about the way rotavirus infects cells. The chemical compounds produced in this study will be evaluated for their ability to prevent rotavirus from infecting cells. It is expected that this project will provide compounds that may ultimately be used as drugs for the treatment of rotavirus.Read moreRead less
Novel control strategies for mosquitoes threatening Australia. Increased global transport and human mobility have led to the spread and establishment of potential disease vectors and pathogens of public health importance in many parts of the world from which these were absent or had been eradicated. Aversion of this risk can be more effective when applying area-wide rather than focal (e.g. insecticide) control efforts. We will further the development of genetic and biological control tactics. We ....Novel control strategies for mosquitoes threatening Australia. Increased global transport and human mobility have led to the spread and establishment of potential disease vectors and pathogens of public health importance in many parts of the world from which these were absent or had been eradicated. Aversion of this risk can be more effective when applying area-wide rather than focal (e.g. insecticide) control efforts. We will further the development of genetic and biological control tactics. We aim to reduce the risks posed by two important dengue-vectoring mosquitoes: the yellow fever and the Asian tiger mosquito. This will lead to environmentally friendly and sustainable mosquito control and protect the Australian population and its regional neighbours against the threats of mosquito-borne disease.Read moreRead less
Statistical and mathematical modelling to improve health care outcomes in hospitals. The aim of this project is to develop new quantitative techniques based on mathematical and statistical modelling that improve the outcomes of health care in hospitals. Hospital outcomes for patients are sub-optimal due to adverse events such as hospital acquired infections and fully stretched facilities. Research from this project will lead to resource usage being optimised using operations research; the tra ....Statistical and mathematical modelling to improve health care outcomes in hospitals. The aim of this project is to develop new quantitative techniques based on mathematical and statistical modelling that improve the outcomes of health care in hospitals. Hospital outcomes for patients are sub-optimal due to adverse events such as hospital acquired infections and fully stretched facilities. Research from this project will lead to resource usage being optimised using operations research; the transmission of hospital acquired infections being better understood using mathematical models; and better monitoring of adverse events and analyses of studies using statistical tools. Opportunities will be provided for hospital staff to acquire knowledge of the significance of these outcomes .Read moreRead less
High resolution single particle analysis of biological macromolecules. One of the great challenges of cell biology is to increase the rate of atomic resolution structure determination, particularly of membrane proteins and macromolecular assemblies. The current rate-limiting step is high quality crystal production. Our goal is to prove that protein structures can be determined to atomic resolution by single-particle analysis. 3D structures will be produced by computationally aligning high-resolu ....High resolution single particle analysis of biological macromolecules. One of the great challenges of cell biology is to increase the rate of atomic resolution structure determination, particularly of membrane proteins and macromolecular assemblies. The current rate-limiting step is high quality crystal production. Our goal is to prove that protein structures can be determined to atomic resolution by single-particle analysis. 3D structures will be produced by computationally aligning high-resolution electron microscope images of individual, randomly oriented molecules. The importance of this project is highlighted by the fact over 120,000 protein sequences are already databased, a number set to increase rapidly as new genome sequencing projects are completed.
Read moreRead less